We suggest that this may be related to the fact that high dietary selenium intake increases MAFLD risk by modulating dysregulation of insulin biosynthesis and secretion as well as stimulating glucagon secretion, insulin resistance and dyslipidemia (33, 34). This evidence concerns the gene INS and metabolic syndrome.